Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial체외막 산소 공급이 필요한 중증 COVID-19 폐렴 환자의 사이토카인 흡착: 무작위, 통제, 공개 라벨 개입 프로토콜, 다기관 시험Article Published on 2021-01-172022-09-11 Journal: BMJ Open [Category] 임상, [키워드] 1:1 acute respiratory distress acute respiratory distress syndrome Adsorption adult intensive & approach approved ARDS baseline Course COVID-19 Critical Critical care Critically ill Critically ill patient critically ill patients cytokine Efficacy elevated ethical committee Ethics evaluate the effect Extracorporeal extracorporeal membrane oxygenation Germany hypothesise IL-6 IL-6 level IL-6 levels include Intensive interleukin-6 Intervention membrane multicentre nine Open-label outcome parallel group Patient protocol randomised randomised controlled reducing respiratory respiratory distress respiratory medicine (see thoracic medicine) severe COVID-19 Severe COVID-19 pneumonia Support syndrome Thoracic treated Treatment Trial university V-V ECMO veno-venous extracorporeal membrane oxygenation [DOI] 10.1136/bmjopen-2020-043345 PMC 바로가기 [Article Type] Article
Deep vein thrombosis with pulmonary thromboembolism in a case of severe COVID-19 pneumonia중증 코로나19 폐렴의 경우 폐혈전색전증을 동반한 심부정맥 혈전증Case Reports Published on 2021-01-152022-09-11 Journal: BMJ case reports [Category] 진단, 치료제, [키워드] Affect Anticoagulants Chest Chest CT chest pain Chest radiograph COVID-19 CTPA D-dimer Deep vein Deep vein thrombosis diabete diabetes diagnosed Doppler dry cough DVT elevated emergency department examination Fever Ground-glass opacities ground-glass opacity heparin lethal lobes lower lobes oxygen oxygen saturation popliteal popliteal veins positive Pulmonary thromboembolism radiological examination Radiological examinations radiology radiology (diagnostics) raised reduced respiratory Respiratory system Severe COVID-19 pneumonia Shortness of breath swelling Tachycardia tachypnoea temperature tested Thromboembolism thrombosis treated Venous Thromboembolism zone [DOI] 10.1136/bcr-2020-240932 PMC 바로가기 [Article Type] Case Reports
Case Report: The Coronavirus Disease 2019 (COVID-19) Pneumonia With Multiple ThromboembolismNeurology Published on 2021-01-122022-11-01 Journal: Frontiers in Neurology [Category] COVID-19, [키워드] acute respiratory syndrome anti-inflammatory treatment Anticoagulant treatment Blood coagulation chest pain clinician coronavirus coronavirus disease COVID-19 demonstrated diagnosed diagnostic value discharged DVT Dyspnea effective Fever Hemorrhagic highlight home quarantine illness onset Infarction infected with COVID-19 laboratory result limb Multiple multiple thromboembolism myalgia occur oxygen supply Patient PCR PCR test Pneumonia polymerase chain presenting Prevalence pulmonary damage remained reported SARS-CoV-2 SARS-CoV-2 virus Severe COVID-19 pneumonia Spread Symptoms tested the patient therapy throat swab Thromboembolism thrombosis thrombotic event Treatment weakness Wuhan, China [DOI] 10.3389/fneur.2020.625272 PMC 바로가기 [Article Type] Neurology
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort StudyNutrition Published on 2021-01-112022-10-31 Journal: Frontiers in Nutrition [Category] COVID-19, [키워드] age Analysis antivirals bacteriotherapy cardiovascular event complementary COVID-19 CRP death died Effect Evidence Gut highlight Hospitalization Host Hydroxychloroquine ICU implication increased risk independent infecting Inflammation intestinal epithelial cells investigated low molecular weight management microbial flora microbiota modulation Mortality Mounting Observational cohort study oral oral bacteriotherapy Patient patients patients hospitalized patients treated patients with COVID-19 Pneumonia Prospective trial reduced risk regimen retrospective SARS-CoV-2 Severe COVID-19 pneumonia subject therapeutic therapy Treatment was used [DOI] 10.3389/fnut.2020.613928 PMC 바로가기 [Article Type] Nutrition
Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab토실리주맙으로 중증 COVID-19 폐렴 및 과염증 증후군의 성공적인 치료Case Reports Published on 2021-01-082022-09-12 Journal: BMJ case reports [Category] 진단, [키워드] Confirmed COVID-19 infection Cytokines death distress Escalation global health Hyperinflammatory syndrome IL-6 IL-6 receptor IMPROVE Infection infections invasive medical management monoclonal antibody Non-invasive occur offer onset of symptoms Patient Pneumonia pneumonia (infectious disease) reduce risk secondary haemophagocytic lymphohistiocytosis Severe COVID-19 pneumonia Supportive treatment survival syndrome therapeutic indications therapeutic indications. Tocilizumab treated Treatment Ventilated [DOI] 10.1136/bcr-2020-238210 PMC 바로가기 [Article Type] Case Reports
Case Report: Ischemic Colitis in Severe COVID-19 Pneumonia: An Unforeseen Gastrointestinal Complication증례 보고서: 중증 COVID-19 폐렴의 허혈성 대장염: 예상치 못한 위장 합병증Case Reports Published on 2021-01-032022-09-10 Journal: The American Journal of Tropical Medicine and Hygi [Category] MERS, 변종, [키워드] angiotensin angiotensin converting enzyme Angiotensin converting enzyme-2 cause clinical manifestation clinical manifestations Coagulopathy Colitis colonic Complication contributing to COVID-19 COVID-19 pneumonia Gastrointestinal GI Tract hemodynamic hypercoagulable Hypercoagulable state intestinal enterocytes involved Ischemia Ischemic Ischemic colitis key factor manifestation Manifestations multifactorial occlusive Pathogenesis pathogenesis of COVID-19 Pathologies pathology Pneumonia receptor receptors SARS-CoV-2 Severe COVID-19 pneumonia severely ill patient severely ill patients thromboembolic thromboembolic complications variant Vasopressor vasopressors [DOI] 10.4269/ajtmh.20-1262 PMC 바로가기 [Article Type] Case Reports
COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation섬망을 초기 징후로 나타내는 COVID-19 감염 후 뇌염Case Reports Published on 2021-01-012022-09-11 Journal: Journal of investigative medicine high impact case [Category] 치료기술, [키워드] abnormal behavior Abnormalities acute respiratory syndrome autoantibody cerebrospinal fluid coronavirus coronavirus disease COVID-19 COVID-19 pneumonia delirium Dexamethasone discharge elevated Encephalitis Fever Immunoglobulin immunoglobulin therapy immunosuppressive immunosuppressive therapy infectious encephalitis inflammatory change initial initial symptom Intravenous immunoglobulin intravenous methylprednisolone magnetic resonance imaging manifestation Methylprednisolone neuronal Older Older adults Patient pleocytosis post-infectious encephalitis. protein concentration respiratory respiratory symptoms RNA SARS-CoV-2 Severe acute respiratory syndrome Severe COVID-19 pneumonia surface protein the patient therapy Tocilizumab with COVID-19 [DOI] 10.1177/23247096211029787 PMC 바로가기 [Article Type] Case Reports
Successful treatment of severe COVID-19 pneumonia with tocilizumab: A series of three cases토실리주맙으로 중증 COVID-19 폐렴의 성공적인 치료: 3건의 일련의 사례Case Reports Published on 2021-01-012022-09-12 Journal: Cardiology journal [Category] 진단, [키워드] Severe COVID-19 pneumonia Treatment [DOI] 10.5603/CJ.a2021.0138 PMC 바로가기 [Article Type] Case Reports
Characterization of pulmonary impairment associated with COVID-19 in patients requiring mechanical ventilationOriginal Article Published on 2021-01-012022-10-29 Journal: Revista Brasileira de Terapia Intensiva [Category] COVID-19, [키워드] 48 hour acute respiratory distress acute respiratory distress syndrome Admission analyzed characterization collected Coronavirus infections COVID-19 COVID-19 patient Descriptive statistics detect Diagnosis diastolic volume echocardiographic Edema pulmonar Evidence hemodynamic hemodynamic instability identify Infecções por coronavírus intubation lung mechanical ventilation objective Patient Pulmonary edema pulmonary impairment Respiratory failure Result Síndrome de dificuldade respiratória SARS-CoV-2 severe COVID-19 Severe COVID-19 pneumonia syndrome Termodiluição Thermodilution were used with COVID-19 [DOI] 10.5935/0103-507X.20210007 PMC 바로가기 [Article Type] Original Article
High Induction of IL-6 Secretion From hUCMSCs Optimize the Potential of hUCMSCs and TCZ as Therapy for COVID-19-Related ARDShUCMSC에서 IL-6 분비의 높은 유도는 COVID-19 관련 ARDS에 대한 치료법으로서 hUCMSC 및 TCZ의 잠재력을 최적화합니다Article Published on 2021-01-012022-09-12 Journal: Cell transplantation [Category] 진단, [키워드] acute respiratory distress analyzed anti-inflammatory effect ARDS Biological Blood Cell cellular Concentration correlation COVID-19 cytokine secretion ELISA evaluated Exogenous expression functional hUCMSC Hyperinflammatory syndrome IL-6 IL-6 level IL-6 levels IL-6 neutralizing antibody IL-6 receptor IL-6R induction Inflammation inhibited inhibitory effect interleukin-6 less Microarray mononuclear cell mRNA expression MTT Neutralizing neutralizing antibody PBMC PBMCs peripheral Potential proliferation reached reported Respiratory failure Responder Severe COVID-19 pneumonia supernatant syndrome TCZ therapeutic potential therapy Tocilizumab treat umbilical was measured was used [DOI] 10.1177/09636897211054481 PMC 바로가기 [Article Type] Article